MedDataX Logo

A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)

NCT ID: NCT00157872

Last Updated: 2017-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-01-07

Study Completion Date

2004-09-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study to compare rofecoxib versus naproxen in the treatment of Chinese patients with rheumatoid arthritis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)

NCT00092352

Osteoarthritis
COMPLETED PHASE3

Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee

NCT00504127

Osteoarthritis
COMPLETED PHASE3

Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients

NCT00650455

Arthritis, Rheumatoid
COMPLETED PHASE4

Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee

NCT00542555

Osteoarthritis
COMPLETED PHASE3

A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)

NCT00092365

Osteoarthritis
COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MK0966; rofecoxib

Intervention Type DRUG

Comparator: naproxen tablet 500 mg

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chinese males or females at least 18 years of age with rheumatoid arthritis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Merck Sharp & Dohme LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Medical Monitor

Role: STUDY_DIRECTOR

Merck Sharp & Dohme LLC

Study Documents

Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.

Document Type: CSR Synopsis

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2005_063

Identifier Type: -

Identifier Source: secondary_id

0966-231

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tanezumab in Osteoarthritis of the Hip or Knee (2)
NCT00863304 COMPLETED PHASE3
Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)
NCT00092742 COMPLETED PHASE3
A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)
NCT00140972 COMPLETED PHASE4
Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee
NCT00928837 COMPLETED NA
A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee
NCT00568295 COMPLETED PHASE3
Tanezumab In Osteoarthritis Of The Knee (2)
NCT00830063 COMPLETED PHASE3
Double-Blind, Double Dummy, Randomized Comparison Study to Evaluate the Efficacy and Safety of Valdecoxib 10 mg Once Daily and Naproxen 500 mg Twice Daily in Treating the Signs and Symptoms of Osteoarthritis of the Knee
NCT00652808 COMPLETED PHASE3
A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome
NCT00140933 TERMINATED PHASE3
A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee
NCT00240773 COMPLETED PHASE3
A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee
NCT01529671 COMPLETED PHASE1
A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study
NCT03936192 WITHDRAWN PHASE3
Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee
NCT00435292 COMPLETED NA
Phase 3 Study of Pelubiprofen Tab. & Celebrex Cap. in Rheumatoid Arthritis Patients
NCT01781702 COMPLETED PHASE3
Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis
NCT05430230 ACTIVE_NOT_RECRUITING PHASE4
A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-39439335 in Patients With Osteoarthritis
NCT01343303 COMPLETED PHASE1
Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip
NCT00809354 TERMINATED PHASE3
TreatMent Of Knee osTeoarthritis wIth chONdroitin Sulfate - the OA MOTION Study
NCT05632783 WITHDRAWN PHASE3
Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee
NCT00790985 COMPLETED NA
Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis
NCT03691818 COMPLETED PHASE2
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the Knee
NCT01688934 COMPLETED PHASE2
A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg Once Daily And Naproxen 500mg Twice Daily In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan
NCT00648258 COMPLETED PHASE3
A Clinical Study to Investigate the Effect on Pain Relief of a Single Dose of JNJ-39439335 in Patients With Chronic Osteoarthritis Pain of the Knee
NCT00933582 COMPLETED PHASE1
A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)
NCT00140920 TERMINATED PHASE4
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
NCT00541489 COMPLETED PHASE3
A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip
NCT03161093 COMPLETED PHASE3